FREE SHIPPING ON ORDERS OVER $150

glutathione adducts quercetin and Its Metabolites: Mechanistic Insights as the Basis of Their Therapeutic Potential in NAFLD and HCC Structure-Based Drug Design of Quercetin

$29.46

Quantity
- +
Description

Cysteine catabolism and the serine biosynthesis pathway support pyruvate production during pyruvate kinase knockdown in pancreatic cancer cells

glutathione adducts quercetin and Its Metabolites: Mechanistic Insights as the Basis of Their Therapeutic Potential in NAFLD and HCC Structure-Based Drug Design of Quercetin

Astrocytes were thawed in a 10 cm 2 culture dish in AMM containing 10 M of Rock-inhibitor Y-27632

glutathione adducts quercetin and Its Metabolites: Mechanistic Insights as the Basis of Their Therapeutic Potential in NAFLD and HCC Structure-Based Drug Design of Quercetin

Raw peak areas were corrected for natural stable isotope abundance and tracer impurity using IsoCorrectoR (23)

glutathione adducts quercetin and Its Metabolites: Mechanistic Insights as the Basis of Their Therapeutic Potential in NAFLD and HCC Structure-Based Drug Design of Quercetin

doi: 10.3390/nu16193277

glutathione adducts quercetin and Its Metabolites: Mechanistic Insights as the Basis of Their Therapeutic Potential in NAFLD and HCC Structure-Based Drug Design of Quercetin

The combination of PETase with adsorption modules, such as hydrophobic binding modules, can greatly facilitate enzyme binding to the substrate and enhance PET degradation efficiency

glutathione adducts quercetin and Its Metabolites: Mechanistic Insights as the Basis of Their Therapeutic Potential in NAFLD and HCC Structure-Based Drug Design of Quercetin

Digital images were captured using an integrated imaging system to evaluate callose deposition levels

glutathione adducts quercetin and Its Metabolites: Mechanistic Insights as the Basis of Their Therapeutic Potential in NAFLD and HCC Structure-Based Drug Design of Quercetin

You may also like

recommand products